Seizures: Diagnosis and management in the outpatient setting

Seminars in Neurology

Volumn 31, Issue 1, 2011, Pages 54-64

  Noe, Katherine H ^a  

^a MAYO CLINIC   (United States)

Author keywords

antiepileptic drug therapy; diagnosis; Epilepsy; seizure

Indexed keywords

CARBAMAZEPINE; CYTOCHROME P450; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; RUFINAMIDE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ANOREXIA; ANTICONVULSANT THERAPY; APHASIA; ARTICLE; ATAXIA; COGNITIVE DEFECT; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTRACEPTION; DEPRESSION; DIPLOPIA; DISEASE CLASSIFICATION; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG TOLERABILITY; EDEMA; ELECTROENCEPHALOGRAPHY; EPILEPSY; FATIGUE; GINGIVA HYPERPLASIA; HAIR LOSS; HEADACHE; HUMAN; HYPERACTIVITY; INSOMNIA; IRRITABILITY; MENSTRUATION DISORDER; MENTAL DETERIORATION; MONOTHERAPY; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RASH; SEDATION; SEIZURE; SIDE EFFECT; SOMNOLENCE; TREMOR; VAGUS NERVE STIMULATION; WEIGHT GAIN; WEIGHT REDUCTION; WORK CAPACITY;

AMBULATORY CARE; ANTICONVULSANTS; DISEASE MANAGEMENT; ELECTROENCEPHALOGRAPHY; HUMANS; SEIZURES; TREATMENT OUTCOME; VAGUS NERVE STIMULATION;

EID: 79951797805     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0031-1271310     Document Type: Article

References (67)

1. Berg A T., Shinnar S. The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology 1991 41 7 965-972
2. Annegers J F., Hauser W A., Lee J R., Rocca W A. Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935-1984. Epilepsia 1995 36 4 327-333
3. Loiseau J, Loiseau P, Guyot M, Duche B, Dartigues J F., Aublet B. Survey of seizure disorders in the French southwest. I. Incide (Pubitemid 20226665)
4. Hauser W A., Annegers J F., Kurland L T. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993 34 3 453-468 (Pubitemid 23184580)
5. MacDonald B K., Cockerell O C., Sander J W., Shorvon S D. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000 123 Pt 4 665-676 (Pubitemid 30162716)
6. Olafsson E, Ludvigsson P, Gudmundsson G, Hesdorffer D, Kjartansson O, Hauser W A. Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study. Lancet Neurol 2005 4 10 627-634 (Pubitemid 41317297)
7. Loiseau P, Loiseau J, Picot M C. One-year mortality in Bordeaux cohort: the value of syndrome classification. Epilepsia 2005 46 Suppl 11 11-14 (Pubitemid 44922030)
8. Manford M, Hart Y M., Sander J W., Shorvon S D. National General Practice Study of Epilepsy (NGPSE): partial seizure patterns in a general population. Neurology 1992 42 10 1911-1917
9. Camfield C S., Camfield P R. Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study. Neurology 2009 73 13 1041-1045
10. Krumholz A, Wiebe S, Gronseth G et al, Quality Standards Subcommittee of the American Academy of Neurology American Epilepsy Society. Practice Parameter: evaluating an apparent unprovoked first seizure in adults (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2007 69 21 1996-2007 (Pubitemid 350145092)
11. Worrell G A., Lagerlund T D., Buchhalter J R. Role and limitations of routine and ambulatory scalp electroencephalography in diagnosing and managing seizures. Mayo Clin Proc 2002 77 9 991-998 (Pubitemid 34977643)
12. Benbadis S R. Errors in EEGs and the misdiagnosis of epilepsy: importance, causes, consequences, and proposed remedies. Epilepsy Behav 2007 11 3 257-262 (Pubitemid 350048472)
13. Wiebe S, Tllez-Zenteno J F., Shapiro M. An evidence-based approach to the first seizure. Epilepsia 2008 49 Suppl 1 50-57
14. Bronen R A., Fulbright R K., Spencer D D. et al. Refractory epilepsy: comparison of MR imaging, CT, and histopathologic findings in 117 patients. Radiology 1996 201 1 97-105 (Pubitemid 26314372)
15. Lawn N D., Bamlet W R., Radhakrishnan K, O'Brien P C., So E L. Injuries due to seizures in persons with epilepsy: a population-based study. Neurology 2004 63 9 1565-1570 (Pubitemid 39507570)
16. Cockerell O C., Johnson A L., Sander J W., Hart Y M., Goodridge D M., Shorvon S D. Mortality from epilepsy: results from a prospective population-based study. Lancet 1994 344 8927 918-921 (Pubitemid 24295878)
17. Lindsten H, Nystrm L, Forsgren L. Mortality risk in an adult cohort with a newly diagnosed unprovoked epileptic seizure: a population-based study. Epilepsia 2000 41 11 1469-1473
18. Lhatoo S D., Johnson A L., Goodridge D M., MacDonald B K., Sander J W., Shorvon S D. Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol 2001 49 3 336-344 (Pubitemid 32202787)
19. Loiseau P, Loiseau J, Picot M C. One-year mortality in Bordeaux cohort: the value of syndrome classification. Epilepsia 2005 46 Suppl 11 11-14 (Pubitemid 44922030)
20. Annegers J F., Shirts S B., Hauser W A., Kurland L T. Risk of recurrence after an initial unprovoked seizure. Epilepsia 1986 27 1 43-50 (Pubitemid 16165748)
21. Hauser W A., Anderson V E., Loewenson R B., McRoberts S M. Seizure recurrence after a first unprovoked seizure. N Engl J Med 1982 307 9 522-528 (Pubitemid 12038483)
22. Kim L G., Johnson T L., Marson A G., Chadwick D W., MRC MESS Study group. Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial. Lancet Neurol 2006 5 4 317-322
23. van Donselaar C A., Schimsheimer R J., Geerts A T., Declerck A C. Value of the electroencephalogram in adult patients with untreated idiopathic first seizures. Arch Neurol 1992 49 3 231-237
24. Kwan P, Brodie M J. Early identification of refractory epilepsy. N Engl J Med 2000 342 5 314-319 (Pubitemid 30075244)
25. Cockerell O C., Johnson A L., Sander J W., Shorvon S D. Prognosis of epilepsy: a review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective population-based study. Epilepsia 1997 38 1 31-46 (Pubitemid 27057479)
26. Mattson R H., Cramer J A., Collins J F. et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985 313 3 145-151 (Pubitemid 15047456)
27. Mattson R H., Cramer J A., Collins J F. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. N Engl J Med 1992 327 11 765-771
28. Brodie M J., Perucca E, Ryvlin P, Ben-Menachem E, Meencke H J., Levetiracetam Monotherapy Study Group. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 2007 68 6 402-408 (Pubitemid 46208740)
29. Marson A G., Al-Kharusi A M., Alwaidh M et al, SANAD Study group. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007 369 9566 1000-1015 (Pubitemid 46436124)
30. Marson A G., Al-Kharusi A M., Alwaidh M et al, SANAD Study group. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007 369 9566 1016-1026 (Pubitemid 46436125)
31. Carpay J A., Aldenkamp A P., van Donselaar C A. Complaints associated with the use of antiepileptic drugs: results from a community-based study. Seizure 2005 14 3 198-206 (Pubitemid 40425269)
32. Harden C L., Meador K J., Pennell P B. et al, American Academy of Neurology American Epilepsy Society. Practice parameter update: management issues for women with epilepsyfocus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009 73 2 133-141
33. Meador K J., Reynolds M W., Crean S, Fahrbach K, Probst C. Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Res 2008 81 1 1-13
34. Meador K J., Baker G A., Browning N et al, NEAD Study Group. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009 360 16 1597-1605
35. Vinten J, Bromley R L., Taylor J, Adab N, Kini U, Baker G A., Liverpool and Manchester Neurodevelopment Group. The behavioral consequences of exposure to antiepileptic drugs in utero. Epilepsy Behav 2009 14 1 197-201
36. Morrow J I., Hunt S J., Russell A J. et al. Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2009 80 5 506-511
37. Kjaer D, Horvath-Puh E, Christensen J et al. Antiepileptic drug use, folic acid supplementation, and congenital abnormalities: a population-based case-control study. BJOG 2008 115 1 98-103 (Pubitemid 350209612)
38. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991 338 8760 131-137
39. Harden C L., Pennell P B., Koppel B S. et al, American Academy of Neurology American Epilepsy Society. Practice parameter update: management issues for women with epilepsyfocus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009 73 2 142-149
40. Harden C L., Hopp J, Ting T Y. et al, American Academy of Neurology American Epilepsy Society. Practice parameter update: management issues for women with epilepsyfocus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009 73 2 126-132
41. Sabers A, Ohman I, Christensen J, Tomson T. Oral contraceptives reduce lamotrigine plasma levels. Neurology 2003 61 4 570-571 (Pubitemid 37025386)
42. Carpay J A., Aldenkamp A P., van Donselaar C A. Complaints associated with the use of antiepileptic drugs: results from a community-based study. Seizure 2005 14 3 198-206 (Pubitemid 40425269)
43. Naritoku D K., Hulihan J F., Schwarzman L K., Kamin M, Olson W H. Effect of cotherapy reduction on tolerability of epilepsy add-on therapy: a randomized controlled trial. Ann Pharmacother 2005 39 3 418-423 (Pubitemid 40270907)
44. Pack A M., Morrell M J., Randall A, McMahon D J., Shane E. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Neurology 2008 70 18 1586-1593 (Pubitemid 351620313)
45. Vestergaard P, Tigaran S, Rejnmark L, Tigaran C, Dam M, Mosekilde L. Fracture risk is increased in epilepsy. Acta Neurol Scand 1999 99 5 269-275 (Pubitemid 29202183)
46. Kwan P, Arzimanoglou A, Berg A T. et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010 51 6 1069-1077
47. Luciano A L., Shorvon S D. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann Neurol 2007 62 4 375-381 (Pubitemid 350105951)
48. Callaghan B C., Anand K, Hesdorffer D, Hauser W A., French J A. Likelihood of seizure remission in an adult population with refractory epilepsy. Ann Neurol 2007 62 4 382-389 (Pubitemid 350105952)
49. Handforth A, DeGiorgio C M., Schachter S C. et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology 1998 51 1 48-55 (Pubitemid 28345358)
50. The Vagus Nerve Stimulation Study Group. A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. Neurology 1995 45 2 224-230
51. DeGiorgio C M., Schachter S C., Handforth A et al. Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia 2000 41 9 1195-1200
52. Murphy M, Smith P D., Wood M et al. Surgery for temporal lobe epilepsy associated with mesial temporal sclerosis in the older patient: a long-term follow-up. Epilepsia 2010 51 6 1024-1029
53. Wiebe S, Blume W T., Girvin J P., Eliasziw M, Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001 345 5 311-318 (Pubitemid 32703233)
54. Engel J Jr, Wiebe S, French J et al, Quality Standards Subcommittee of the American Academy of Neurology American Epilepsy Society American Association of Neurological Surgeons. Practice parameter: temporal lobe and localized neocortical resections for epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology 2003 60 4 538-547 (Pubitemid 36246066)
55. Callaghan N, Garrett A, Goggin T. Withdrawal of anticonvulsant drugs in patients free of seizures for two years. A prospective study. N Engl J Med 1988 318 15 942-946 (Pubitemid 18094987)
56. Sillanp M, Schmidt D. Prognosis of seizure recurrence after stopping antiepileptic drugs in seizure-free patients: A long-term population-based study of childhood-onset epilepsy. Epilepsy Behav 2006 8 4 713-719
57. Tennison M, Greenwood R, Lewis D, Thorn M. Discontinuing antiepileptic drugs in children with epilepsy. A comparison of a six-week and a nine-month taper period. N Engl J Med 1994 330 20 1407-1410
58. Baker G A., Jacoby A, Buck D, Stalgis C, Monnet D. Quality of life of people with epilepsy: a European study. Epilepsia 1997 38 3 353-362 (Pubitemid 27147650)
59. Gilliam F, Kuzniecky R, Faught E, Black L, Carpenter G, Schrodt R. Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia 1997 38 2 233-236 (Pubitemid 27093337)
60. Jacoby A, Baker G A., Steen N, Potts P, Chadwick D W. The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study. Epilepsia 1996 37 2 148-161 (Pubitemid 26043793)
61. Strine T W., Kobau R, Chapman D P., Thurman D J., Price P, Balluz L S. Psychological distress, comorbidities, and health behaviors among U.S. adults with seizures: results from the 2002 National Health Interview Survey. Epilepsia 2005 46 7 1133-1139 (Pubitemid 40962160)
62. Jones J E., Hermann B P., Barry J J., Gilliam F G., Kanner A M., Meador K J. Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav 2003 4 Suppl 3 S31-S38 (Pubitemid 37428235)
63. Johnson E K., Jones J E., Seidenberg M, Hermann B P. The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia 2004 45 5 544-550 (Pubitemid 38581567)
64. Boylan L S., Flint L A., Labovitz D L., Jackson S C., Starner K, Devinsky O. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology 2004 62 2 258-261 (Pubitemid 38167135)
65. Cramer J A., Blum D, Reed M, Fanning K, Epilepsy Impact Project Group. The influence of comorbid depression on quality of life for people with epilepsy. Epilepsy Behav 2003 4 5 515-521 (Pubitemid 37407610)
66. Camfield P, Camfield C. Idiopathic generalized epilepsy with generalized tonic-clonic seizures (IGE-GTC): a population-based cohort with > 20 year follow up for medical and social outcome. Epilepsy Behav 2010 18 1-2 61-63
67. Shareef Y S., McKinnon J H., Gauthier S M., Noe K H., Sirven J I., Drazkowski J F. Counseling for driving restrictions in epilepsy and other causes of temporary impairment of consciousness: how are we doing? Epilepsy Behav 2009 14 3 550-552